@article {49883,
	title = {Autoantibodies against Nε-carboxymethyl lysine and methylglyoxal modified albumin are associated with cardiovascular risk in type 2 diabetes},
	journal = {International Journal of Diabetes in Developing Countries},
	volume = {45},
	year = {2025},
	month = {DEC},
	pages = {1104-1110},
	type = {Article},
	abstract = {<p>
	{Background Albumin is an abundant plasma protein which gets modified with advanced glycation end products (AGEs) predominantly in diabetic condition. AGE modification induces immune response and autoantibodies are generated which play an important role in disease pathology. Objective This study aimed to illustrate the role of autoantibodies against N epsilon-carboxymethyl lysine (CML) and methylglyoxal (MG) modified albumin in diabetic cardiovascular complications. MethodsType-2 diabetes subjects were enrolled and further grouped into stress test positive or stress test negative based on treadmill stress test (TMT). Autoantibody titer was quantified by ELISA assay for CML-modified albumin (stress test positive</p>
},
	keywords = {AGE, Atherosclerosis, Diabetes, Glycation, Immune response, ROC},
	issn = {0973-3930},
	doi = {10.1007/s13410-024-01435-0},
	author = {Patil, Yugendra R. and Tiwari, Shalbha and Momin, Abdulrahaman A. and Unnikrishnan, A. G. and Kulkarni, Mahesh J.}
}
